Arrhythmias & electrophysiology

Anticoagulation in critically ill patients with new-onset atrial fibrillation: Insights from a retrospective cohort study

Heart RhythmPublished Retrospective cohort study

Corrected 23 Oct 2026: Measure wording clarified; no values changed.

Authors' conclusion

Anticoagulant prescription at hospital discharge for patients with NOAF during ICU stay was associated with longer survival.

Study context

Population
Critically ill patients with new-onset atrial fibrillation (AF) during ICU admission (MIMIC-IV, Beth Israel Deaconess Medical Center, 2008–2019), excluding pre-existing AF, cardiac surgery admissions and previous anticoagulant usematched cohort 495 per group
Participants
495 vs 2,021
Exposure
Anticoagulation at hospital discharge vs no anticoagulation
  • Anticoagulation (ACO)n = 495
  • Non-ACOn = 2,021reference
Outcome
Long-term survival post-hospital discharge
Methodological detailspropensity-score matched
  • Propensity-score matched

Main finding

Long-term survival

Hazard ratio

0.72

95% CI 0.58–0.89, event not clearly stated

P = 0.003

By group

ACOvs Non-ACO
HR 0.72 (95% CI 0.58–0.89), event not clearly stated; P = 0.003

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Survival, PSM analysis censored at 90 days, 1 year and 5 yearsACOvs Non-ACOCensored at 90 days0.63 (0.43–0.94)P = 0.02
Survival, PSM analysis censored at 90 days, 1 year and 5 yearsACOvs Non-ACOCensored at 1 year0.55 (0.41–0.793)P < 0.001
Survival, PSM analysis censored at 90 days, 1 year and 5 yearsACOvs Non-ACOCensored at 5 years0.7 (0.56–0.88)P = 0.002

3 other sensitivity analyses

Findings remained consistent

Original publication

Anticoagulation in critically ill patients with new-onset atrial fibrillation: Insights from a retrospective cohort study. Heart Rhythm. Published 6 May 2025. doi:10.1016/j.hrthm.2025.02.040

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.